Sentences with phrase «garner shareholder support»

Because ICCR members and staff have been filing resolutions for over four decades, we have a great deal of expertise in how to write a strong shareholder proposal that will pass muster at the SEC and how to garner shareholder support at the AGM.

Not exact matches

The LSE and TMX realized they wouldn't be able to garner enough shareholder support, and the acquisition died.

The three members, Ellen Futter, David Cote and James Crown, for whom shareholder advocacy group ISS had urged shareholders to withhold support, garnered less than 60 percent support each..

Research indicates, for instance, that companies with majority (rather than plurality) voting for directors are more apt to adopt shareholder proposals that garner majority support, and that many chief financial officers are willing to forgo investments in projects expected to be profitable in the longer term in order to meet analysts» quarterly earnings estimates.

And finally, we will argue that sometimes voting support is modest in early years but later garners significant shareholder backing as knowledge about an issue accumulates.»

The results show two other members of Magna's board also garnered just 38 per cent support from shareholders, while all other directors got more than 84 per cent support.

A well - known activist investor suggested that Coca - Cola (NYSE: KO) might be taken private and that the notion might garner support from nine percent shareholder Warren Buffett.

Policies presently outlined in Section 162 (m) have garnered robust shareholder support in 2017.

Glanbia had agreed in April to sell its Irish dairy business to its majority shareholder Glanbia Co-operative Society for about $ 343m but the proposals narrowly failed to garner enough support from the membership.

If Mr. Rahim can garner the support from the two activist funds and drive cost cutting while providing better leadership at the firm, shareholders could be rewarded.

As a brief overview, the Management and Board have embarked upon a failed merger that garnered virtually no support from its shareholders, and was opposed by ISS, and continued on that path until the date of the special shareholders meeting and scheduled vote, spending lavishly in a failed effort to close it; attempted to implement substantial new options to itself, a plan opposed by ISS and the shareholders, which was withdrawn; continually paid itself outrageous sums of the shareholders money over the past three years; rejected highly qualified outside board members with deep, broad healthcare company experience supported by its shareholders; held many Board and Committee meetings with nothing to show for it; formed a new Strategic Transactions Committee that is highly paid but that has produced no deals for the shareholders to consider or for any outside valuation experts to formally review; spent lavishly on accountants, auditors and counsel; failed to successfully hire any outside professional negotiators and finally extinguish or remove the outstanding lease obligations; distributed no cash to the shareholders despite holding excess amounts; formed no special purpose entity to hold any royalty and milestone rights and payments for the benefit of its shareholders; and thus generally failed in its fiduciary duties to shareholders.